But it still didn’t reduce mortality or improve systolic function. Epistaxis and other non surgical bleeding although significant is exactly not what they were hoping to cut down.LVAD Costs 150,000 ... the state invested as they were looking for a successful wean. Stem cells to help improve myocardial regeneration. I am sure bleeding can be managed
To inject 10,000-15000 $ to reduce epistaxis by 60%
mmm not sure
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-583
-
- There are more pages in this discussion • 456 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3634 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 3635 | 1 |
View Market Depth
| Last trade - 09.42am 30/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable